Pr1 169-177 (HLA-A*02:01)

Pr1 169-177 (HLA-A*02:01)
€57.50 *

Prices plus VAT plus shipping costs

Delivery time 2-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.

Amount in mg:

5 mg

  • EP06994_1
Antigen Peptide Myeloblastin precursor HLA-A*0201 (VLQELNVTV) for stimulation of human... more
Product information "Pr1 169-177 (HLA-A*02:01)"

Antigen Peptide Myeloblastin precursor HLA-A*0201 (VLQELNVTV) for stimulation of human Proteinase 3-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. PR1 (VLQELNVTV) is a human leukocyte antigen-A2 (HLA-A2)-restricted leukemia-associated peptide from proteinase 3 (P3) and neutrophil elastase (NE) that is recognized by PR1-specific cytotoxic T lymphocytes that contribute to cytogenetic remission of acute myeloid leukemia (AML). VLQELNVTV is a linear peptidic epitope (epitope ID69719) studied as part of Myeloblastin from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays, B cell assays and MHC ligand assaysAntigen Peptide Myeloblastin precursor HLA-A*0201 (VLQELNVTV) for stimulation of human Proteinase 3-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. PR1 (VLQELNVTV) is a human leukocyte antigen-A2 (HLA-A2)-restricted leukemia-associated peptide from proteinase 3 (P3) and neutrophil elastase (NE) that is recognized by PR1-specific cytotoxic T lymphocytes that contribute to cytogenetic remission of acute myeloid leukemia (AML). VLQELNVTV is a linear peptidic epitope (epitope ID69719) studied as part of Myeloblastin from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays, B cell assays and MHC ligand assaysAntigen Peptide Myeloblastin precursor HLA-A*0201 (VLQELNVTV) for stimulation of human Proteinase 3-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. PR1 (VLQELNVTV) is a human leukocyte antigen-A2 (HLA-A2)-restricted leukemia-associated peptide from proteinase 3 (P3) and neutrophil elastase (NE) that is recognized by PR1-specific cytotoxic T lymphocytes that contribute to cytogenetic remission of acute myeloid leukemia (AML). VLQELNVTV is a linear peptidic epitope (epitope ID69719) studied as part of Myeloblastin from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays, B cell assays and MHC ligand assays

Available downloads:

 
Sequence:VLQELNVTV
Delivery: 2-3 days
C-Terminus:OH
N-Terminus:H
Purity:95%
Amount:1 mg
Counter Ion:TFA
Allele:HLA-A*02:01
ACTH (1-39) (human) ACTH (1-39) (human)
From €241.50 *
ACTH (18-39) (human) ACTH (18-39) (human)
From €172.50 *
P60 217-225 (H-2Kd) P60 217-225 (H-2Kd)
From €57.50 *
HA HA
From €57.50 *
LL - 37 LL - 37
From €201.25 *
HJURP (HLA-A*24:02) HJURP (HLA-A*24:02)
From €57.50 *
Viewed